×

收藏- 会员访问记录

网页标题:
×

注册 用户

用 户 名:
联 系 人:
性  别:
密  码:
重复密码:
电子邮箱:
邮箱验证码:
固定电话:
传  真:
手  机:
单位名称:
通信地址:
首选栏目:
我已经认真阅读并同意《 服务条款》
×

找回密码

  • 1.选择找回方式
  • 2.确认验证信息
  • 3.修改密码
  • 4.修改成功
  • 找回方式:
  • 用 户 名:
  • 手机号码:

 您现在位置: -医药产业 >> 研究报告 >> English reports >> English reports >> 浏览医药行业研究报告

Cephalosporin Bulk Drug Industry Report

作者:wangchun   来源:本站原创    点击数:0    更新时间:2006-9-13 10:45:20

[关键字]: Cephalosporin Bulk Drug Industry Report

讯:


Research Report on Chinese Bulk Cephalosporin Industry

Publisher: Orient Health Electronic Commercial(Beijing)co.,Ltd
Published:  July 2006 
Format:  Hardcopy and Adobe PDF 
Price:  US$6,700 
Contact: Mr. Bian chenghua   Ms. Wu huifang
Tel.: 86-10-68012929-2116/2101             Fax:  86-10-68012929-2008
E-mail: bianch@healthoo.com   wuhf@healthoo.com                      
//m.limatoxi.com

Directory
1、Industry scale of China's chemical API
 1.1 Basic situation and product structure of chemical API
 1.2 Developing trend of chemical API lately years
 1.3 Output structure of 24 Categories of chemical API last year
 1.4 Output and production value of chemical API in differnet provinces
 1.5 Output and share of antibiotic bulk drugs

2 Overview of antibiotic bulk drugs
 2.1 Categories
 2.2 Therapeutic mechanisms
 2.3 Cephalosporin nucleus series
 2.4 Product structure

3 7-ACA series
 3.1 About 7-ACA
    3.1.1 Output,production capacity,status of import and export,key
 enterprises
    3.1.2 Price trend
    3.1.3 Trend of import and export
    3.1.4 Connections of 7-ACA with lower-stream product
    3.1.5 Market forecast
 3.2 Analysis about Cefazolin
    3.2.1 Output,production capacity,status of import and export,key
 enterprises
    3.2.2 Price trend
    3.2.3 Market forecast
    3.2.4 Connections of Cefazolin with lower-stream product
 3.3 Analysis about Ceftriaxone
    3.3.1 Output,production capacity,status of import and export,key
 enterprises
    3.3.2 Price trend
    3.3.3 Connections of Ceftriaxone with lower-stream product
    3.3.4 Market forecast
    3.3.5 Export trend
 3.4 Analysis about Cefoperazone
    3.4.1 Output,production capacity,status of import and export,key
 enterprises
    3.4.2 Price trend
    3.4.3 Status of production and sales and Market forecast
    3.4.4 Connections of Cefoperazone with lower-stream product
    3.4.5 Export trend 
 3.5 Analysis about Cefotaxime
    3.5.1 Output,production capacity,key enterprises
    3.5.2 Price trend
    3.5.3 Export status 
    3.5.4 Status of production and sales and Market forecast
    3.5.5 Connections of Cefotaxime with lower-stream product
 3.6 Analysis about Ceftazidime
    3.6.1 Output,production capacity,status of import and export,key
 enterprises
    3.6.2 Price trend
    3.6.3 Connections of Ceftazidime with lower-stream product
    3.6.4 Status of production and sales and Market forecast
 3.7 Analysis about Ceftazidime
    3.7.1 Output,production capacity,key enterprises
    3.7.2 Price trend and import & export
    3.7.3 Status of production and sales and Market forecast

4 7-ADCA series
 4.1 Output,production capacity,enterprise's share
    4.1.1 Output,production capacity,status of import and export,key
 enterprises
    4.1.2 Price trend
    4.1.3 Connections of 7-ADCA with lower-stream product
    4.1.4 Status of production and sales and Market forecast
 4.2 Cefalexin
    4.2.1 Output,production capacity,status of import and export,key
 enterprises
    4.1.2 Price trend
    4.2.3 Connections of Cefalexin with lower-stream product
    4.2.4 Connections of Cefalexin with lower-stream product
 4.3 Cefradine
    4.3.1 Output,production capacity,status of import and export,key
 enterprises
    4.3.2 Price trend
    4.3.3 Status of production and sales and Market forecast
    4.3.4 Connections of Cefradine with lower-stream product
 4.4 Cefadroxil
    4.4.1  Output,production capacity,status of import and export,key 
 enterprises
    4.4.2 Price trend
    4.4.3 Status of production and sales and Market forecast
    4.4.4 Connections of Cefradine with lower-stream product
 4.5 Other antibiotic bulk drugs

5 About key enterprise
 5.1 Shijiazhuang Pharmaceutical Group Co.,Ltd
 5.2 Shandong Lukang Pharmaceutical Group Co.,Ltd
 5.3 Fujian antibiotic Pharmaceutical Co.,Ltd
 5.4 Suzhou Dongrui Pharmaceutical Co.,Ltd
 5.5 Zhuhai Federal Pharmaceutical Company, Ltd
 5.6 Shandong xinhua-chemfermPharmaceutical Co., Ltd
 5.7 North China pharmaceutical Group Corporation
 5.8 Harbin General Pharmaceutical Factory
 5.9 Zhejiang Yongning Pharmaceutical Factory 
 5.10 Guangzhou Baiyunshan Pharmaceutical Co., Ltd
Cephalosporin Bulk Drug Industry Report
注册后,我们会为你提供报告样本并为您提供更全面的咨询服务
您的姓名  称谓: 先生女士
手机号码 
电子邮件 
单位名称 

服务热线

  • 联系项目:86-10-68012929-2103
  • 订购报告:86-10-68012929-2103
  • 邮件订购:leigy@healthoo.com
Baidu
map